innoser logo slogan

Accelerate Your Preclinical Research With InnoSer’s Innovative Methods.

Customizing in vitro and in vivo services for your success.

Recently At InnoSer

A day in the life of InnoSer data scientist Sander Klerk

To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...

CONNECT: Connecting Cerebral Organoids to the Blood-Brain Barrier

The CONNECT project aims to develop a novel organoid-chip connecting the blood vasculature to the brain to mimic the blood-brain barrier (BBB). This complex 3D-model can be used to mimic aspects of drug delivery into the human brain, a key process that is often not...

A day in the life of InnoSer’s Intern Marketing Analysts Meilin Berkhoff & Amber Schonk

  Meilin and Amber are both students of Leiden University completing their Masters in Biomedical Sciences Management. As part of their study requirements, Amber and Meilin are with us for a total of 6 months and will step into the role of marketing analysts. They...
InnoSer mouse models

We Specialize In

Kidney Disease (PKD)

Learn More

Parkinson’s Disease

Learn More


Learn More

Alzheimer’s Disease

Learn More


Combining In Vivo And In Vitro

By our state-of-the-art methods from organoids to genetically engineered mice, we provide reliability and transferability in your results.

Low success rates of drugs that are able to go from bench to the clinic continue to disappoint not only researchers and pharmaceutical companies but also patients and their families. The resulting expenses affect the costs of all drugs that reach the market.

InnoSer cell culture laboratory

This calls for more stringent criteria at the preclinical phase, ensuring only the drugs that are effective and safe for humans continue to the clinical phases. InnoSer excels in combining in vitro and in vivo disease modelling to offer the most reliable screening platforms.

By developing in-vitro technologies and knowledge that offer higher predictive capacity, we support the transition to a world that relies less on animal testing.


Tell Us About Your Work

We always keep close contact with our customers to identify and understand their needs better. All our services can be customized for your project requirements.


Academic And Commercial Expertise

“We truly enjoyed working with the InnoSer team. They bring an outstanding scientific knowledge into the oncology field in combination with high flexibility. InnoSer provided us with and executed a preclinical study project tailored to our needs, and within the agreed timelines. We will definitely work with InnoSer for our future drug development needs.”


Ad van de Gorp PhD, CEO Cythura Therapeutics

“Starting a biotech company was something completely new for me. InnoSer supported me in developing the study protocol and with all additional hassle like ethical protocols, logistics, ordering study materials etc. We worked closely with the InnoSer staff and I truly appreciate their professionalism and dedication.”


 Joost van Bree, CEO Saillant Therapeutics


+32 (0)11 14 07 68


InnoSer België NV

Agoralaan A bis
3590 Diepenbeek




InnoSer Nederland BV

Zernikedreef 9
2333 CK Leiden
The Netherlands


Accelerate Your Preclinical Research.

By signing up, you agree to receive promotional emails from InnoSer.

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please check our privacy page.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing.